Dyne Therapeutics Inc
(NAS:DYN)
$
26
0.05 (0.19%)
Market Cap: 2.27 Bil
Enterprise Value: 1.85 Bil
PE Ratio: 0
PB Ratio: 4.69
GF Score: 37/100 Dyne Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023 / 06:35PM GMT
Release Date Price:
$14
(-2.00%)
Unidentified Analyst
Good afternoon, everyone. Welcome to day two of the BofA Healthcare Conference. My name is [Jason Szymanski]. I'm one of the new healthcare SMID cap analysts here at BofA. It's my pleasure to introduce for this next session Dyne Therapeutics, Josh Brumm, President and CEO; and Wildon Farwell, CMO. Gentlemen, thank you for being here.
Josh Brumm
Dyne Therapeutics, Inc. - President & CEO
Thanks for inviting us.
Wildon Farwell
Dyne Therapeutics, Inc. - Chief Medical Officer
Thank you.
Questions & Answers
Unidentified Analyst
Perfect. Well, let's dive right into Q&A, maybe to start more broadly, can you remind us about your FORCE platform? And specifically, where do you see its advantages, especially within the field of muscle diseases?
Josh Brumm
Dyne Therapeutics, Inc. - President & CEO
Yeah. Thanks, Jason. First, I'll just mention forward-looking statements as customary. If you have any questions,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot